Register
Medicines reference
Product

Xyla

Xylazine · Interchemie werken "De Adelaar" Eesti AS

1 form: solution. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Used for: Sedation

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
20 mg/ml, Solution · Cat Cat Sedation · Intramuscular / Subcutaneous: 3 mg/kg once Georgia Yes, veterinary
In force until 22 May 2028
Veterinary (National Food Agency)
In the register: ქსილა
№ 000289; 72-11
Verified on: 29 Oct 2026
20 mg/ml, Solution · Dog Dog Sedation · Intramuscular / Intravenous: 1–3 mg/kg once Georgia Yes, veterinary
In force until 22 May 2028
Veterinary (National Food Agency)
In the register: ქსილა
№ 000289; 72-11
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Xyla 20 mg/ml, Solution

xylazine 20 mg/ml, solution for injection
Composition / strength
Xylazine20 mg/ml
Formulation Type
Solution
Administration route
Intramuscular, Intravenous, Subcutaneous
Registration
Georgia Yes, veterinary
In force until 22 May 2028
Veterinary (National Food Agency)
In the register: ქსილა
№ 000289; 72-11
Verified on: 29 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 18 Oct 2026
Cat
WeightSedation · Intramuscular / Subcutaneous
Any weight 3 mg/kg
  • Sedation · Intramuscular / Subcutaneous (once): Label: 0.15 ml/kg (3 mg/kg) IM or SC. Not in late pregnancy; not with mechanical obstruction of the alimentary tract (vomiting is common in cats). Slows heart and breathing.
Source:
Interchemie label
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Xyla - Xylazine 2% injection, product information
interchemie.com, 2026
Dog
WeightSedation · Intramuscular / Intravenous
Any weight 1–3 mg/kg
  • Sedation · Intramuscular / Intravenous (once): Label: 0.05-0.15 ml/kg (1-3 mg/kg) IM or IV. Not in late pregnancy; not with mechanical obstruction of the alimentary tract (vomiting). Slows heart and breathing.
Source:
Interchemie label
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Xyla - Xylazine 2% injection, product information
interchemie.com, 2026

Known Contraindications

  • Critical
    Do not use in the last trimester of pregnancy (uterine contractions).
    Sources: Czech SPC
  • Critical
    Do not use with gastric dilatation or torsion or oesophageal obstruction.
    Sources: Czech SPC
  • Critical
    Dogs and cats: do not use with diabetes mellitus (xylazine raises blood glucose).
    Sources: Czech SPC
  • Critical
    Do not use if hypersensitive to xylazine or excipients.
    Sources: Czech SPC
  • Critical
    Dogs and cats: do not use in illness with vomiting. Do not combine with neuroleptics.
    Sources: Czech SPC
  • Warning
    Heart or circulatory disease: use with caution (Rometar); contraindicated in cardiopulmonary disease (Xylazin bio 2%).
    Sources: Czech SPC
  • Warning
    Respiratory disease: use with caution; contraindicated in cardiopulmonary disease (Xylazin bio 2%).
    Sources: Czech SPC
  • Caution
    Liver dysfunction: use with caution.
    Sources: Czech SPC
  • Caution
    Kidney dysfunction: use with caution.
    Sources: Czech SPC

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.